NDC 50102-130-01 - CHATEAL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-130
- Requested NDC
- 50102-130-01
- Package NDCs from labels
- 50102-130-00, 50102-130-01, 50102-130-48, 50102-130-10, 50102-130-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CHATEAL - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-27 | HUMAN PRESCRIPTION DRUG LABEL |
| Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-130-03 | 2023-02-24 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-48 | 2023-02-24 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-03 | 2023-01-30 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
| 50102-130-48 | 2023-01-30 | Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-130-00 | EA - Each | 50102-130 | dcb62401-8949-464e-ab16-85f9c6f4c40d | 1 | 2022-06-06 |
| 50102-130-01 | EA - Each | 50102-130 | b8bb767c-e280-45f7-828d-4a8aaae9c21c | 1 | 2013-02-13 |
| 50102-130-03 | EA - Each | 50102-130 | 61c25f8e-2546-4292-98d9-3172853ce2f1 | 1 | 2017-09-11 |
| 50102-130-10 | EA - Each | 50102-130 | 4a3fd139-d25f-40ed-939c-42f8b7d58d0e | 1 | 2017-09-11 |
| 50102-130-48 | EA - Each | 50102-130 | 1a4669e5-b979-4386-ba8b-04d4f4b7e28e | 1 | 2013-02-13 |
| 50102-130-90 | EA - Each | 50102-130 | 3536e405-15d6-482b-949b-31b922af726b | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Etonogestrel and Ethinyl Estradiol Vaginal | ETONOGESTREL AND ETHINYL ESTRADIOL VAGINAL | AvKARE | 05e172aa-e18a-427b-e063-6294a90ae22f | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| LEVONORGESTREL | LEVONORGESTREL | YYBA CORP | 5a71b870-9a0a-7997-e063-6294a90a882c | 2026-09-01 | Warnings | 5W7SIA7YZW |
| SheWise | LEVONORGESTREL | GLENMARK THERAPEUTICS INC., USA | 7be13a7e-b4ff-4fe1-82a6-f9914596d72a | 2026-07-15 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | GLENMARK THERAPEUTICS INC., USA | 07567b80-d8a1-41c0-95e4-33afa584bbc4 | 2026-07-15 | Warnings | 5W7SIA7YZW |
| Gwyn Lo | NORELGESTROMIN AND ETHINYL ESTRADIOL | Viatris Specialty LLC | e92741f4-87fe-429f-b5b5-c558ed5f4fa9 | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Twirla | LEVONORGESTREL/ETHINYL ESTRADIOL | Agile Therapeutics, Inc. | bcaf8db0-1750-425d-b008-255b5e7a9cc6 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U 5W7SIA7YZW |
| OPTION 2 | LEVONORGESTREL | L. Perrigo Company | 7d7b9e61-9f3d-477d-b74d-b0cc725f9bba | 2026-06-25 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | Rugby Laboratories | 076126e4-9d76-45cd-a86b-5b35c56b620a | 2026-05-13 | Warnings | 5W7SIA7YZW |
| LEADER Emergency Contraceptive Levonorgestrel | LEVONORGESTREL | Cardinal Health 110, LLC. DBA Leader | d1e33615-0a98-4223-833d-843c758d9db7 | 2026-05-06 | Warnings | 5W7SIA7YZW |
| My Choice | LEVONORGESTREL | OHM LABORATORIES INC | 500d9418-69a8-f4f3-e063-6394a90a9b66 | 2026-04-22 | Warnings | 5W7SIA7YZW |
| norelgestromin and ethinyl estradiol | NORELGESTROMIN AND ETHINYL ESTRADIOL | Zydus Pharmaceuticals USA Inc. | 10fa1458-c8ed-4197-922a-1ba7271d2b02 | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| norelgestromin and ethinyl estradiol | NORELGESTROMIN AND ETHINYL ESTRADIOL | Zydus Lifesciences Limited | 7c2cc8ab-db6d-4a1c-ae74-e0ef27e2f3a9 | 2026-04-16 | 423D2T571U | |
| Norethindrone Acetate and Ethinyl Estradiol | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | A-S Medication Solutions | 38924c83-53aa-4279-8f0e-1a5d8f5fd8ad | 2026-03-26 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Climara Pro | ESTRADIOL AND LEVONORGESTREL | Bayer HealthCare Pharmaceuticals Inc. | 184d3092-7fc6-4375-816b-1ab06bb99cfd | 2026-03-26 | Boxed warning, Warnings, Adverse reactions | 5W7SIA7YZW |
| LEVONORGESTREL | LEVONORGESTREL | Camber Consumer Care Inc | 2e22d0c4-b308-4a02-b2b0-2c06fb91d1e5 | 2026-03-23 | Warnings | 5W7SIA7YZW |
| Junel FE | JUNEL FE | Direct_Rx | ea62a66e-d45d-11be-e053-2a95a90a7801 | 2026-03-17 | Warnings, Adverse reactions | 423D2T571U |
| Skyla | LEVONORGESTREL | Bayer HealthCare Pharmaceuticals Inc. | 9f44ff35-e052-49cd-a1c2-0bfd87d49309 | 2026-03-04 | Warnings, Adverse reactions | 5W7SIA7YZW |
| Restart | LEVONORGESTREL | Winx Health Inc. | 0cdf198e-c114-b9fa-e063-6294a90a566a | 2026-02-24 | Warnings | 5W7SIA7YZW |
| Levonorgestrel | LEVONORGESTREL | YYBA Corp | 49008f10-8a70-3c08-e063-6294a90a44a3 | 2026-02-03 | Warnings | 5W7SIA7YZW |
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 44fbc5ae-5682-471f-a12a-955e8b4d233a | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U 5W7SIA7YZW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.